CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $73.24B, higher than 95% of all stocks globally
- PositionCurrent ratio is 0.89×, lower than 95% of its Medical Instruments & Supplies peers (median 2.67×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.88%Above 5Y avg (1.64%)
Annual Rate
EUR 4.00Paid annual
Payout Ratio
74.8%Moderate
Payback Period
35.7 yr
Last Ex-Dividend
May 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
63.76BEUR73.24B · vs all stocks (USD)
Trailing P/E
26.44xvs Medical Instruments & Supplies peers
Revenue (TTM)
29.28BEUR33.64B · vs all stocks (USD)
Profit Margin
8.52%vs Medical Instruments & Supplies peers
Beta
0.5460xvs all stocks
52-Week Change
-49.44%vs all stocks
Market Capitalization
63.76BEUR73.24B · vs all stocks (USD)
Enterprise Value
79.11BEUR90.86B · vs all stocks (USD)
Trailing P/E
26.44xvs Medical Instruments & Supplies peers
Forward P/E
17.51xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.22xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.66xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.70xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
13.52xvs Medical Instruments & Supplies peers
Profit Margin
8.52%vs Medical Instruments & Supplies peers
Operating Margin
15.37%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.69%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.72%vs Medical Instruments & Supplies peers
Revenue (TTM)
29.28BEUR33.64B · vs all stocks (USD)
Revenue per Share (TTM)
63.46EURUpdated Sep 20, 2026Quarterly Revenue Growth
5.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
17.58BEUR20.19B · vs all stocks (USD)
EBITDA (TTM)
6.60BEUR7.58B · vs all stocks (USD)
Net Income (TTM)
2.49BEUR2.86B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
12.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
5.29BEUR6.07B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.29BEUR3.77B · vs all stocks (USD)
Trailing Annual Dividend Rate
4.00EURUpdated Sep 20, 2026Trailing Annual Dividend Yield
2.88%vs all stocks
5-Year Average Dividend Yield
1.64%vs all stocks
Payout Ratio
74.77%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
604.00MEURFY2025 · Dec 31, 2025Revenue
28.49BEURFY2025 · Dec 31, 2025Cost of Goods Sold
11.24BEURFY2025 · Dec 31, 2025Gross Profit
17.25BEURFY2025 · Dec 31, 2025Operating Income
3.38BEUR3.88B · vs all stocks (USD)
Pre-tax Income
3.19BEURFY2025 · Dec 31, 2025Income Tax Expense
752.00MEURFY2025 · Dec 31, 2025Net Income
2.44BEURFY2025 · Dec 31, 2025EBIT
3.51BEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.60BEURFY2025 · Dec 31, 2025Research & Development
664.00MEURFY2025 · Dec 31, 2025Selling, General & Administrative
12.98BEURFY2025 · Dec 31, 2025Other Operating Expenses
249.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
85.00MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
314.00MEURFY2025 · Dec 31, 2025EPS (Basic)
5.04EURFY2025 · Dec 31, 2025EPS (Diluted)
4.98EURFY2025 · Dec 31, 2025Basic Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.44BEURFY2025 · Dec 31, 2025Minority Interests (P&L)
-128.00MEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
2.44BEURFY2025 · Dec 31, 2025Free Cash Flow
922.00MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.54BEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.44BEURFY2025 · Dec 31, 2025Stock-based Compensation
280.00MEURFY2025 · Dec 31, 2025Other Non-cash Items
158.00MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-446.00MEURFY2025 · Dec 31, 2025Capital Expenditures
-1.51BEURFY2025 · Dec 31, 2025Net Acquisitions
-911.00MEURFY2025 · Dec 31, 2025Other Investing Activity
12.00MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.41BEURFY2025 · Dec 31, 2025Long-term Debt Issuance
992.00MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-2.47BEURFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.50BEURFY2025 · Dec 31, 2025Common Stock Repurchase
-376.00MEURFY2025 · Dec 31, 2025Common Dividends Paid
-547.00MEURFY2025 · Dec 31, 2025Other Financing Charges
1.42BEURFY2025 · Dec 31, 2025Net Financing Cash Flow
556.00MEURFY2025 · Dec 31, 2025Shares Outstanding
459.59MSharesUpdated Sep 20, 2026Float Shares
292.07MSharesUpdated Sep 20, 2026% Held by Insiders
36.99%vs all stocks
% Held by Institutions
27.83%vs all stocks
Total Cash (MRQ)
1.93BEUR2.22B · vs all stocks (USD)
Total Cash per Share (MRQ)
4.20EURUpdated Sep 20, 2026Total Debt (MRQ)
15.32BEUR17.59B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3836xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.8890xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
85.33EURUpdated Sep 20, 2026Total Assets
63.90BEUR73.39B · vs all stocks (USD)
Total Current Assets
12.01BEURFY2025 · Dec 31, 2025Total Liabilities
24.40BEURFY2025 · Dec 31, 2025Total Non-current Assets
51.89BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
13.50BEURFY2025 · Dec 31, 2025Total Current Liabilities
10.90BEURFY2025 · Dec 31, 2025Cash
3.16BEURFY2025 · Dec 31, 2025Cash Equivalents
386.00MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.54BEURFY2025 · Dec 31, 2025Accounts Receivable
3.64BEURFY2025 · Dec 31, 2025Inventory
3.54BEURFY2025 · Dec 31, 2025Accounts Payable
2.88BEURFY2025 · Dec 31, 2025Short-term Debt
3.68BEURFY2025 · Dec 31, 2025Other Current Liabilities
1.56BEURFY2025 · Dec 31, 2025Long-term Debt
10.71BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
34.00MEURFY2025 · Dec 31, 2025Common Stock (Book)
83.00MEURFY2025 · Dec 31, 2025Retained Earnings
2.31BEURFY2025 · Dec 31, 2025Total Shareholders' Equity
39.49BEUR45.36B · vs all stocks (USD)
Treasury Stock
25.00MEURFY2025 · Dec 31, 202552-Week Low
138.30EURUpdated Sep 20, 202652-Week High
323.80EURUpdated Sep 20, 202652-Week Change
-49.44%vs all stocks
Beta
0.5460xvs all stocks
50-Day MA
161.80EURUpdated Sep 20, 2026200-Day MA
202.34EURUpdated Sep 20, 2026Avg 10-Day Volume
802.52KSharesUpdated Sep 20, 2026Avg 30-Day Volume
695.84KSharesUpdated Sep 20, 2026Diluted EPS (TTM)
5.35EURUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.89×, lower than 95% of its Medical Instruments & Supplies peers (median 2.67×)Significant
Current ratio: 0.89Industry median: 2.67Industry P5: 1.07Peers compared: 38.00
Financial Health
Altman Z-Score 2.27: grey zoneSignificant
Altman Z-Score: 2.27
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $73.24B, higher than 95% of all stocks globallySignificant
Market cap (USD): 73,237,859,693.416Global P95: 25,554,966,472.502
Revenue is $33.64B, higher than 95% of all stocks globallySignificant
Revenue (USD): 33,636,457,194.373Global P95: 15,291,475,445.58
Levered free cash flow is $3.77B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 3,773,979,610.877Global P95: 1,207,183,969.279
Companies that share the same coordination system — how they create, deliver, or capture value.
Naura Technology Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Cummins Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Ferrari N.V.
Tier 1ProductionThroughput-Bound ConversionAttentionInterface
General Motors Company
Tier 1ProductionThroughput-Bound ConversionRiskFlow
Motorola Solutions, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Samsung Electro-Mechanics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dayou Plus Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Illinois Tool Works Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hyundai Motor Co.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Ecolab Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Vital Farms Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Bentley Systems, Incorporated Class B
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Primoris Services Corporation
1 interpretationMulti-Year Revenue, Profit, And Income Growth